PCA3 and benign prostatic hyperplasia: We then evaluated the expression levels of lncRNA PCA3 and MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) in a large cohort of PCa and BPH (benign prostatic hyperplasia) participants.